InMed Pharmaceuticals INM Stock
InMed Pharmaceuticals Price Chart
InMed Pharmaceuticals INM Financial and Trading Overview
| InMed Pharmaceuticals stock price | 1.33 USD |
| Previous Close | 1.35 USD |
| Open | 1.37 USD |
| Bid | 0.99 USD x 200 |
| Ask | 1.72 USD x 200 |
| Day's Range | 1.33 - 1.39 USD |
| 52 Week Range | 0.58 - 2.5 USD |
| Volume | 28.34K USD |
| Avg. Volume | 916.31K USD |
| Market Cap | 7.31M USD |
| Beta (5Y Monthly) | 0.978 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.84 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
INM Valuation Measures
| Enterprise Value | 5.07M USD |
| Trailing P/E | N/A |
| Forward P/E | -0.21280001 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 6.6169157 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -0.523 |
Trading Information
InMed Pharmaceuticals Stock Price History
| Beta (5Y Monthly) | 0.978 |
| 52-Week Change | -40.62% |
| S&P500 52-Week Change | 14.57% |
| 52 Week High | 2.5 USD |
| 52 Week Low | 0.58 USD |
| 50-Day Moving Average | 1.42 USD |
| 200-Day Moving Average | 1.18 USD |
INM Share Statistics
| Avg. Volume (3 month) | 916.31K USD |
| Avg. Daily Volume (10-Days) | 61.41K USD |
| Shares Outstanding | 5.49M |
| Float | 3.13M |
| Short Ratio | 0.21 |
| % Held by Insiders | 0.061% |
| % Held by Institutions | 51.26% |
| Shares Short | 15.88K |
| Short % of Float | 0.28% |
| Short % of Shares Outstanding | 0.28% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:20 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | June 30, 2026 |
| Most Recent Quarter (mrq) | June 30, 2026 |
| Next Fiscal Year End | June 30, 2027 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -66.46% |
| Return on Equity (ttm) | -156.76% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -9689845 USD |
| Net Income Avi to Common (ttm) | -11804805 USD |
| Diluted EPS (ttm) | -2.84 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 2.23M USD |
| Total Cash Per Share (mrq) | 0.41 USD |
| Total Debt (mrq) | 0 USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 1.369 |
| Book Value Per Share (mrq) | 0.201 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -8643513 USD |
| Levered Free Cash Flow (ttm) | -3187294 USD |
Profile of InMed Pharmaceuticals
| Country | United States |
| State | BC |
| City | Vancouver |
| Address | 500 West Georgia Street |
| ZIP | V6B 0M3 |
| Phone | 604 669 7207 |
| Website | https://www.inmedpharma.com |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 6 |
InMed Pharmaceuticals Inc. operates as a pharmaceutical drug development company in the United States. The company researches and develops cannabinoid-based pharmaceuticals products. Its product candidates include INM-901 for Alzheimer's disease, INM-089 for dry age-related macular degeneration, and INM-755, a cannabinol cream. The company was formerly known as Cannabis Technologies Inc. and changed its name to InMed Pharmaceuticals Inc. in October 2014. InMed Pharmaceuticals Inc. was incorporated in 1981 and is based in Vancouver, Canada.
Q&A For InMed Pharmaceuticals Stock
What is a current INM stock price?
InMed Pharmaceuticals INM stock price today per share is 1.33 USD.
How to purchase InMed Pharmaceuticals stock?
You can buy INM shares on the Tech Market Small exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for InMed Pharmaceuticals?
The stock symbol or ticker of InMed Pharmaceuticals is INM.
Which industry does the InMed Pharmaceuticals company belong to?
The InMed Pharmaceuticals industry is Drug Manufacturers - Specialty & Generic.
How many shares does InMed Pharmaceuticals have in circulation?
The max supply of InMed Pharmaceuticals shares is 5.49M.
What is InMed Pharmaceuticals Price to Earnings Ratio (PE Ratio)?
InMed Pharmaceuticals PE Ratio is now.
What was InMed Pharmaceuticals earnings per share over the trailing 12 months (TTM)?
InMed Pharmaceuticals EPS is -2.84 USD over the trailing 12 months.
Which sector does the InMed Pharmaceuticals company belong to?
The InMed Pharmaceuticals sector is Healthcare.
InMed Pharmaceuticals INM included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
{{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
US Tech Composite
IXIC
US
|
27190.86 USD — |
+1.19
|
6.86B USD — | 27112.24 USD — | 27353.68 USD — | — - | 6.86B USD — |
|
US Tech Australia Completion Cap
NQAUCCN
US
|
1088.27 AUD 760.23 USD |
0
|
— — | 1083.1 AUD 756.62 USD | 1088.97 AUD 760.72 USD | — - | — — |
|
US Tech Health Care
IXHC
US
|
1302.61 USD — |
-0.29
|
— — | 1298.55 USD — | 1311.62 USD — | — - | — — |
- {{ link.label }} {{link}}
